The WAVEchip has enabled your biophysical analysis for years. Its patented microfluidic design without microvalves supports a broad range of samples, from large particles to crude samples and harsh solvents. Now, the GCI R&D team is excited to present the KYMAchip, the next generation chip for the WAVEsystem. The new design incorporates precisely defined channels, reducing channel-to-channel variability and simplifying data evaluation. Reduced rise time results in even sharper signal transitions. With enhanced robustness, the KYMAchip can be redocked, allowing it to be stored and reused.
Palestrante
- David Baumstark - Associate Scientist, 2Bind
- Simone Hageneder - R&D application scientist, Malvern Panalytical
Mais informações
Who should attend?
- Scientists and researchers interested in binding kinetics of challenging targets
- Those looking to unlock biophysical analysis breakthroughs faster and more confidently with the WAVEsystem
What will you learn?
- Discover the new KYMAchip for the WAVEsystem, a Creoptix GCI technology
- Unlock biophysical analysis breakthroughs faster and more confidently with the WAVEsystem